Home / Resource Library / Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphomaSafety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma